Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Lebanon Cardiology Associates and The Good Samaritan Hospital team up to implement hypothermia protocol for improved cardiac care

Lebanon Cardiology Associates and The Good Samaritan Hospital team up to implement hypothermia protocol for improved cardiac care

Clinical trial data of Medtronic Arctic Front CryoAblation Catheter System for treating AF to be presented

Clinical trial data of Medtronic Arctic Front CryoAblation Catheter System for treating AF to be presented

St. Jude Medical reports net sales of $1.203 billion in fourth-quarter of 2009

St. Jude Medical reports net sales of $1.203 billion in fourth-quarter of 2009

AFib: NAVISTAR THERMOCOOL Catheter provides better outcomes compared to drug therapy

AFib: NAVISTAR THERMOCOOL Catheter provides better outcomes compared to drug therapy

Ablation therapy better than drug therapy for heart rhythm disorder

Ablation therapy better than drug therapy for heart rhythm disorder

Abaxis' new CRP assay receives FDA marketing clearance

Abaxis' new CRP assay receives FDA marketing clearance

Special report on A-Fib to be premiered in RLTV's Healthline series

Special report on A-Fib to be premiered in RLTV's Healthline series

Sanofi-aventis U.S. brings national experts together to help aging Americans with AFib

Sanofi-aventis U.S. brings national experts together to help aging Americans with AFib

New technique could bring immense benefits for patients with irregular heart rhythm

New technique could bring immense benefits for patients with irregular heart rhythm

St. Jude Medical completes second interoperability testing process for Merlin.net Patient Care Network

St. Jude Medical completes second interoperability testing process for Merlin.net Patient Care Network

Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance

Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance

New issue from Annals of Internal Medicine

New issue from Annals of Internal Medicine

Japanese MHLW approves St. Jude Medical's Genesis spinal cord stimulation system

Japanese MHLW approves St. Jude Medical's Genesis spinal cord stimulation system

Novel technique eliminates radiation exposure to patients and medical providers

Novel technique eliminates radiation exposure to patients and medical providers

Ibutilide Fumarate Injection launched

Ibutilide Fumarate Injection launched

Variations in SNPs involved in modulating electrical impulse that govern working of heart discovered

Variations in SNPs involved in modulating electrical impulse that govern working of heart discovered

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

NewCardio announces two encouraging validation studies related to CardioBip

NewCardio announces two encouraging validation studies related to CardioBip

ARYx Therapeutics receives guidance in writing from FDA on tecarfarin

ARYx Therapeutics receives guidance in writing from FDA on tecarfarin

Cardima receives Shonin approval from the Japanese MHLW to market PATHFINDER catheters

Cardima receives Shonin approval from the Japanese MHLW to market PATHFINDER catheters

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.